echemi logo
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Shanghai pharmaceutical cephalosporading capsules are evaluated by generic consistency

    Shanghai pharmaceutical cephalosporading capsules are evaluated by generic consistency

    • Last Update: 2021-01-19
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit
    On January 7, Shanghai Pharmaceutical Holding Subsidiary, XinAIA Bank, received the "Notice of Approval of Drug Supplemental Application" (Notice No. 2020B05358) issued by the State Drug Administration on cephalosporading capsules (hereinafter referred to as "the drug"), which is evaluated consistently by generic drugs.
    cephalosporine capsules are mainly suitable for acute pharyngitis, tonsillitis, otitis media, bronchitis and pneumonia and other respiratory infections, genitourinary tract infections and skin soft tissue infections caused by sensitive bacteria.
    the drug as an oral preparation and should not be used for serious infections, it was developed by the United States- and first marketed in Ireland in 1972.
    January 2020, The New Asia Bank filed an application with the State Drug Administration for a consistent evaluation of the drug's generics.
    date of this announcement, the company's consistent evaluation of the drug has invested about 5.98 million yuan in research and development costs.
    as of this announcement date, the main manufacturers of the drug in China are Shanghai Shiguibao Pharmaceutical Co., Ltd., Yangzijiang Pharmaceutical Group Co., Ltd., Shandong Xinhua Pharmaceutical Co., Ltd.
    IQVIA database, the purchase amount of the drug hospital in 2019 was RMB31.76 million.
    2019, the drug will have sales of 8.24 million yuan.
    This article is an English version of an article which is originally in the Chinese language on and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to with relevant evidence.